Form Type: Ownership Filings: Date Filer Form Type View; This page was last updated on 3/5/2021 by MarketBeat.com Staff. Description Date Filed ... Filings 6-K. Reported ASTRAZENECA PLC. Tweet Share E … ASTRAZENECA PLC: AZN (Nasdaq Global Market) Enter your Email to Learn More: Form (Filer) Received ( Period) 6-K: ASTRAZENECA PLC: 01/15/21 (01/15/21) 6-K: ASTRAZENECA PLC: 01/06/21 (01/06/21) 6-K: ASTRAZENECA PLC: 01/04/21 (01/04/21) 6-K: ASTRAZENECA … Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Filter, compare, and track stocks. Filing year. In connection with the proposed transaction, on February 19, 2021, AstraZeneca PLC (“AstraZeneca”) filed a registration statement on Form F-4 with the SEC, which includes a document that serves as a preliminary prospectus of AstraZeneca and a preliminary proxy statement of Alexion (the ‘proxy statement/prospectus’). (Date of Event Which Requires Filing of this Statement) ... AstraZeneca PLC . The institutional investor purchased 67,204 shares of the company’s stock, valued at approximately $3,360,000. Article Stock Quotes (1) February 26, 2021 6:54 AM EST. A high-level overview of AstraZeneca PLC (AZN) stock. Merck & Co., Inc. Media Contacts: Tracy Ogden, 908-740-1747 or Pamela Eisele, 267-305-3558 or Investor Contacts: Teri Loxam, 908-740-1986 or Amy Klug, 908-740-1898 . View the AZN U.S. Securities and Exchange Commission reporting information. Participants in the Solicitation . Download. Important Additional Information . Phase 1/2 Study will Evaluate Combination of IMFINZI ® (durvalumab) and FOTIVDA ® (tivozanib) in First-Line HCC. Under the agreement with AstraZeneca, Pieris has the option to co-develop and co-commercialize PRS-060 and two of the additional programs initiated under the collaboration. Visit this page to review all historical SEC filings, including 10k reports, by Mallinckrodt Pharmaceuticals. SEC Filings. RNS Number: 2473 P AstraZeneca PLC 16 February 2021 16 February 2021 11:15 GMT. March 10, 2021: 0001209191-21-019413.pdf. Track performance, allocation, dividends, and risks. Filings … Filings Reported. AstraZeneca (NASDAQ:AZN) 's stock had its "buy" rating restated by equities researchers at Berenberg Bank in a research note issued to investors on Tuesday, The Fly reports. The documents filed by AstraZeneca with the SEC may be obtained free of charge at the SEC's website at www.sec.gov. Get daily stock ideas top-performing Wall Street analysts. Check the Appropriate Box if a Member of a Group (See Instructions) (a) o (b) x (Joint filers) 3. Dividend yield 2.8: The number of times the dividend could have been paid out from net profits. Shared Voting Power 0 shares . Description Report of Foreign Issuer. 0001558370-21 … Requesting Public Documents : Accessing EDGAR Data. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom. SEC Use Only . AstraZeneca PLC (NYSE: AZN) Q4 2020 earnings call dated Feb. 11, 2021 Corporate Participants: Pascal Soriot — Chief Executive Officer David Fredrickson — Executive Vice-President, Oncology Business Unit Ruud Dobber — Executive Vice-President, BioPharmaceuticals Business Unit… Other institutional investors also recently added to or reduced their stakes in the company. SEC Forms List (PDF versions) About EDGAR. Article Stock Quotes (2) FREE Breaking News Alerts from StreetInsider.com! Reports and SEC Filings; Add To Favorites. They contain mainly financial information. SEC Filings include 13F quarterly reports, 13D/G events and more. Descriptions of SEC Forms. … Co. discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology and Respiratory and Inflammation. Filing date Form Description Filing Group View ; 03/08/21: PRE 14A: A preliminary proxy statement providing notification matters to be brought to a vote. Annotate, download XLSX & look up similar tables. Download. Form 425 ALEXION PHARMACEUTICALS, Filed by: ASTRAZENECA PLC . Description Report of Foreign Issuer. 4. Items per page. Filing year. 0001209191-21-019413.xls. 0001209191-21-019413.rtf. 30 Days of MarketBeat All Access for $1.00. Pieris’ respiratory franchise includes PRS-060 and a series of other Anticalin proteins that are currently being developed in partnership with AstraZeneca. 5. Date Filed 04 March 2021. SEC Filings SEC Filings Group. My Favorite. Payout ratios above 75% are not desirable because they may not be sustainable. and Exchange Commission (“SEC”) filings of AstraZeneca plc (“AstraZeneca” or the “Company”), Company releases, and analyst reports, media reports and other publicly disclosed reports and information about the Company. SEC Filings AstraZeneca (NASDAQ:AZN) SEC Filings. Date Filed 09 March 2021. This page shows recent SEC filings related to AstraZeneca Plc. SEC Filings; Analyst Coverage; Events & Presentations; Investor Resources; Careers; Fusion Pharmaceuticals Announces Collaboration with AstraZeneca to Develop and Commercialize Next-Generation Radiopharmaceuticals and Combination Therapies . WhaleWisdom ... AstraZeneca is a prescription-based biopharmaceutical company. Quick EDGAR Tutorial . Aktien-Screener. Find the latest SEC Filings data for AstraZeneca Plc (AZNCF) at Nasdaq.com. Here you'll find links to a complete list of filings available through EDGAR and instructions for searching the EDGAR database. Form 6-K ASTRAZENECA PLC For: Feb 11. The registration statement has not yet Form Description Filing date View; 4: Statement of changes in beneficial ownership of securities. The company's average rating score is 2.62, and is based on 10 buy ratings, 1 hold rating, and 2 sell ratings. Search EDGAR Comment Letters. Sole Voting Power 14,650,334 shares(1) 6. Stock Ideas and Recommendations. SEC Filings. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. AstraZeneca PLC ADR secarticle SEC filings breakout by MarketWatch. … 2. Full text search: Search 6-K - Current Report of Foreign Issuer - DESIGNATION OF EU HOME MEMBER STATE FOR EU SECURITIES REGULATION PURPOSES 03-04 sec.gov FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities … Search SEC filings. Click to remove it from your list. SEC filings SEC Filing Keyword Search (View SEC Groupings descriptions) Group. SEC filings are those documents that we are required to file by virtue of our listing on Nasdaq. This page has been added to your list of favorites. Proxy Filings. Trexquant Investment LP purchased a new stake in AstraZeneca PLC (NASDAQ:AZN) during the fourth quarter, Holdings Channel reports. Filings 6-K. Reported ASTRAZENECA PLC. SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 … Return to this page later. StreetInsider.com Top Tickers, 2/11/2021 . Collaboration Combines Fusion's Targeted Alpha Therapies (TATs) Platform with AstraZeneca's Antibody and Oncology Portfolio to … Date Filed 03 March 2021. These documents are also available for viewing on the SEC website at www.sec.gov. Märkte; Werkzeuge Portfolios. Save time by adding this page to your list of favorites. EDGAR Indexes Daily Indexes; Full and … AstraZeneca and Merck will share the development and commercialization ... and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov). Filings 6-K. Reported ASTRAZENECA PLC. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Search for Company Filings. How to Invest After a Turbulent 2020 Election; AZN has been the topic of several other research reports. Citizenship or Place of Organization United Kingdom . AstraZeneca has a deep-rooted heritage in oncology and offers a quickly growing portfolio of new medicines that has the potential to transform patients' lives and the Company's future. See how executives trade . SEC filings and transcripts for Astrazeneca plc, including financials, news, proxies, indentures, prospectuses, and credit agreements Insiderhandel. ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline – AZN WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AstraZeneca PLC (NASDAQ: AZN) between May 21, 2020 and November 20, 2020, inclusive (the "Class Period"), of the important March 29, 2021 lead plaintiff deadline. E-mail Address. Number of Shares Beneficially Owned by Each Reporting Person With. ... "Investors" and under the heading "SEC Filings" or by contacting Alexion's Investor Relations Department at investorrelations@alexion.com. On your next visit, you'll find a shortcut to this page in the main menu. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring. AlphaValue raised AstraZeneca to a "reduce" rating in a research note on Wednesday, December 30th. Download. SEC filings. Description Report of Foreign Issuer.